"Ceftizoxime" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.
| Descriptor ID |
D015296
|
| MeSH Number(s) |
D02.065.589.099.249.190.190.145 D02.886.665.074.190.190.145 D03.633.100.300.249.190.190.145
|
| Concept/Terms |
Ceftizoxime Sodium- Ceftizoxime Sodium
- Sodium, Ceftizoxime
- Ceftizoxime Monosodium Salt
- Monosodium Salt, Ceftizoxime
- Salt, Ceftizoxime Monosodium
|
Below are MeSH descriptors whose meaning is more general than "Ceftizoxime".
Below are MeSH descriptors whose meaning is more specific than "Ceftizoxime".
This graph shows the total number of publications written about "Ceftizoxime" by people in this website by year, and whether "Ceftizoxime" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ceftizoxime" by people in Profiles.
-
Ceftizoxime-induced hemolysis secondary to combined drug adsorption and immune-complex mechanisms. Transfusion. 2001 Jul; 41(7):893-7.
-
First two cases of immune hemolytic anemia associated with ceftizoxime. Transfusion. 1999 Aug; 39(8):838-44.
-
Treatment of ciprofloxacin- and ceftizoxime-induced resistant gram-negative bacilli. Am J Med. 1987 Apr 27; 82(4A):80-6.
-
Treatment and long-term follow-up of foot infections in patients with diabetes or ischemia: a randomized, prospective, double-blind comparison of cefoxitin and ceftizoxime. Clin Ther. 1987; 10 Suppl A:36-49.
-
Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model. J Antimicrob Chemother. 1986 Jul; 18(1):51-63.
-
Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a neutropenic site in rabbits. J Antimicrob Chemother. 1985 Jan; 15 Suppl A:207-19.
-
Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model. Antimicrob Agents Chemother. 1984 May; 25(5):545-52.
-
Comparison study of the kinetics of ceftizoxime penetration into extravascular spaces with known surface area/volume ratio in vitro and in vivo in rabbits. Antimicrob Agents Chemother. 1983 Jan; 23(1):49-53.
-
Comparative tissue and extravascular fluid concentrations of ceftizoxime. J Antimicrob Chemother. 1982 Nov; 10 Suppl C:105-16.
-
Pharmacokinetics, protein binding, and extravascular distribution of ceftizoxime in normal subjects. Antimicrob Agents Chemother. 1982 Nov; 22(5):878-81.